CD8A and neoplasm: Preclinical studies have demonstrated that TS activation induces also systemic, tumor-specific immuno-modulation mediated by CD8+ T cells which involves up-regulation of both cytolytic and memory cells [37] and microvessels closure that may help in overcoming tumor resistance [38,39].